4.7 Review

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Article Public, Environmental & Occupational Health

Adherence of the General Public to Self-Protection Guidelines During the COVID-19 Pandemic

Parnian Jabbari et al.

Summary: This study investigated the adherence and knowledge of the general public in Tehran, Iran, regarding the use of personal protective equipment (PPE). The results showed that while there were individuals who did not use PPE correctly, the majority of participants were receptive towards education on preventive measures through public media.

DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2022)

Letter Emergency Medicine

COVID-19 pandemic is not the time of trial and error

Kawthar Mohamed et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Editorial Material Cell Biology

The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis

Ehsan Shojaeefar et al.

Summary: Vitamin D may affect the infection and development of COVID-19 through various mechanisms, such as influencing ACE2 expression and increasing natural antibiotics. However, the effects of Vitamin D may have a dual nature, both beneficial for preventing the disease and potentially exacerbating the condition.

CELL BIOLOGY INTERNATIONAL (2021)

Review Cell Biology

Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

Simin Seyedpour et al.

Summary: This study systematically evaluated recent in vitro and in vivo investigations targeting SARS-CoV-2 cell entry, finding that SARS-CoV-2 primarily enters host cells through the S protein utilizing ACE2 or CD147 as receptors. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms mainly focus on targeting virus receptors on the host, neutralizing spike protein, interfering with virus fusion to host cells, and disrupting endosomal and non-endosomal dependent pathways.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Review Virology

Microfluidic devices for detection ofRNAviruses

Arefeh Basiri et al.

Summary: Finding a rapid, easy-to-use, and cost-effective diagnostic method is crucial for controlling the Covid-19 outbreak. Microfluidic systems show promise as an alternative method for detecting viral RNA with faster, cheaper, and higher sensitivity capabilities.

REVIEWS IN MEDICAL VIROLOGY (2021)

Letter Public, Environmental & Occupational Health

Country Quarantine During COVID-19: Critical or Not?

Noosha Samieefar et al.

DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2021)

Editorial Material Infectious Diseases

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Philippe Colson et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Review Infectious Diseases

Discovery and development of safe-in-man broad-spectrum antiviral agents

Petter I. Andersen et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Letter Biochemistry & Molecular Biology

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

Xin Liu et al.

JOURNAL OF GENETICS AND GENOMICS (2020)

Letter Medicine, General & Internal

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang et al.

LANCET (2020)

Letter Medicine, General & Internal

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Peter Richardson et al.

LANCET (2020)

Editorial Material Medicine, General & Internal

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Clark D. Russell et al.

LANCET (2020)

Article Multidisciplinary Sciences

Drug trials under way

Alice Klein

NEW SCIENTIST (2020)

Article Infectious Diseases

2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness

Robyn Ralph et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2020)

Article Pharmacology & Pharmacy

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Canrong Wu et al.

ACTA PHARMACEUTICA SINICA B (2020)

Article Public, Environmental & Occupational Health

Case Report: Death due to COVID-19 in Three Brothers

Sedigheh Yousefzadegan et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Article Public, Environmental & Occupational Health

All together to Fight COVID-19

Sara Momtazmanesh et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Editorial Material Medicine, Research & Experimental

COVID-19: Developing from an Outbreak to A Pandemic

Sara Hanaei et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Editorial Material Medicine, Research & Experimental

Central Nervous System Involvement in COVID-19

Leila Jahanshahlu et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Editorial Material Medicine, Research & Experimental

SARS-CoV-2-A Tough Opponent for the Immune System

Mahsa Golshani Nasab et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Review Cell Biology

Lymphopenia in COVID-19: Therapeutic opportunities

Nazanin Fathi et al.

CELL BIOLOGY INTERNATIONAL (2020)

Article Immunology

Immune-epidemiological parameters of the novel coronavirus - a perspective

Amene Saghazadeh et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)

Article Neurosciences

The involvement of the central nervous system in patients with COVID-19

Kiarash Saleki et al.

REVIEWS IN THE NEUROSCIENCES (2020)

Review Medicine, Research & Experimental

The urgent need for integrated science to fight COVID-19 pandemic and beyond

Negar Moradian et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?

Fateme Babaha et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)

Editorial Material Virology

Challenges for management of immune thrombocytopenia during COVID-19 pandemic

Kamal Kant Sahu et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Review Medicine, Research & Experimental

Monoclonal antibody as a potential anti-COVID-19

Leila Jahanshahlu et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Medical Laboratory Technology

COVID-19: Transmission, prevention, and potential therapeutic opportunities

Melika Lotfi et al.

CLINICA CHIMICA ACTA (2020)

Article Pharmacology & Pharmacy

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting

Sourena Sharifkashani et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Editorial Material Immunology

Quantity does not equal quality: Scientific principles cannot be sacrificed

Piotr Rzymski et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Review Medicine, Research & Experimental

The immune system and COVID-19: Friend or foe?

Fereshteh Yazdanpanah et al.

LIFE SCIENCES (2020)

Review Medicine, Research & Experimental

The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19

Amir Hossein Mansourabadi et al.

LIFE SCIENCES (2020)

Editorial Material Medicine, Research & Experimental

Genetic predisposition models to COVID-19 infection

Farzaneh Darbeheshti et al.

MEDICAL HYPOTHESES (2020)

Review Neurosciences

Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19)

Niloufar Yazdanpanah et al.

REVIEWS IN THE NEUROSCIENCES (2020)

Letter Medicine, Research & Experimental

COVID-19 and picotechnology: Potential opportunities

Navid Rabiee et al.

MEDICAL HYPOTHESES (2020)

Review Biochemistry & Molecular Biology

Interleukin-6 and severe COVID-19: a systematic review and meta-analysis

Helia Mojtabavi et al.

EUROPEAN CYTOKINE NETWORK (2020)

Letter Public, Environmental & Occupational Health

Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling

Sora Yasri et al.

ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2020)

Letter Biochemistry & Molecular Biology

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia

Wei Zhou et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Pharmacology & Pharmacy

Broad-spectrum coronavirus antiviral drug discovery

Allison L. Totura et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Pharmacology & Pharmacy

Molecular dynamics simulations and novel drug discovery

Xuewei Liu et al.

EXPERT OPINION ON DRUG DISCOVERY (2018)

Article Medicine, General & Internal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

David Moher et al.

SYSTEMATIC REVIEWS (2015)

Review Biochemistry & Molecular Biology

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs

Joong Sup Shim et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)

Review Pharmacology & Pharmacy

Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs

Lei Xie et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)

Review Microbiology

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Lanying Du et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Review Pharmacology & Pharmacy

Multi-target therapeutics: when the whole is greater than the sum of the parts

Grant R. Zimmermann et al.

DRUG DISCOVERY TODAY (2007)

Article Virology

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Martin J. Vincent et al.

VIROLOGY JOURNAL (2005)

Article Biochemistry & Molecular Biology

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

N Yamamoto et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Biochemistry & Molecular Biology

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

JE Blanchard et al.

CHEMISTRY & BIOLOGY (2004)